Document › Details

Biocrates Life Sciences AG. (12/7/10). "Press Release: Biocrates Expands Management Board. New Chief Technology Officer (CTO) Dr. Ralph Zahn". Innsbruck.

	Region	Innsbruck
	Country	Austria
	Organisation	Biocrates Life Sciences AG
	Organisation 2	ETH Zürich (ETHZ)
	Product	metabolomics
	Product 2	biomarker discovery services
	Person	Schnegg, Elgar (Biocrates Life Sciences 200806– CEO before Sandoz/Hexal Commercial Operations Austria before FMCG)

The Austrian BIOCRATES Life Sciences AG, pioneer in the development of metabolic Biomarkers, has employed Dr. Ralph Zahn as new CTO (Chief Technology Officer), since October 2010. „The constant development of our products and the affiliated technical
and scientific assignments made a CTO necessary. Dr. Zahn and his expertise are a valuable
enrichment to our organisation“, says Elgar Schnegg, MBA, CEO of BIOCRATES.

He holds a PhD in natural sciences and has a wealth of experience in the field of biotech. After he graduated from biology, he worked as research associate and earned the doctors degree in 1994 at the Max-Planck-Institute for Biochemistry in Munich. At the Cambridge University he absolved a postgraduate doctors degree. He habilitated 2001 at the Institute for Molecular Biology and Biophysics at the Eidgenössischen Technischen Hochschule in Zurich.

During his career, he was managing director at BioSafety GmbH and founder and CEO of allprion AG.

About BIOCRATES Life Sciences AG

Founded in 2002 in Innsbruck, Austria, BIOCRATES has dedicated its research activities to the youngest addition to the ‘omics’ quartet of systems biology, i.e., metabolomics, the study of the body’s small-molecule metabolites. The company’s research and development focus rests on the identification and validation of powerful biomarker panels that help identify disease risk, diagnose diseases, assess disease severity, and guide treatment and on the development of ‘companion diagnostics,’ i.e., biomarkers that help assess how a new drug works in the body and identify patients most likely to respond to a treatment.

For questions: Michael Leitner, Public Health PR
Tel.: +43/1/602 05 30-0, e-mail: michael.leitner@publichealth.at

Record changed: 2011-12-27

Follow Us!

Top News

Upcoming Events

Associations

Partners

Biocrates Life Sciences AG. (12/7/10). "Press Release: Biocrates Expands Management Board. New Chief Technology Officer (CTO) Dr. Ralph Zahn". Innsbruck.

More documents for Biocrates Life Sciences AG